1. Home
  2. PLRX vs EVLV Comparison

PLRX vs EVLV Comparison

Compare PLRX & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • EVLV
  • Stock Information
  • Founded
  • PLRX 2015
  • EVLV 2013
  • Country
  • PLRX United States
  • EVLV United States
  • Employees
  • PLRX N/A
  • EVLV N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • EVLV Computer peripheral equipment
  • Sector
  • PLRX Health Care
  • EVLV Technology
  • Exchange
  • PLRX Nasdaq
  • EVLV Nasdaq
  • Market Cap
  • PLRX 641.5M
  • EVLV 590.8M
  • IPO Year
  • PLRX 2020
  • EVLV N/A
  • Fundamental
  • Price
  • PLRX $11.24
  • EVLV $3.14
  • Analyst Decision
  • PLRX Strong Buy
  • EVLV Strong Buy
  • Analyst Count
  • PLRX 7
  • EVLV 5
  • Target Price
  • PLRX $40.50
  • EVLV $5.60
  • AVG Volume (30 Days)
  • PLRX 551.3K
  • EVLV 1.5M
  • Earning Date
  • PLRX 02-26-2025
  • EVLV 02-27-2025
  • Dividend Yield
  • PLRX N/A
  • EVLV N/A
  • EPS Growth
  • PLRX N/A
  • EVLV N/A
  • EPS
  • PLRX N/A
  • EVLV N/A
  • Revenue
  • PLRX N/A
  • EVLV $89,220,000.00
  • Revenue This Year
  • PLRX N/A
  • EVLV $28.84
  • Revenue Next Year
  • PLRX N/A
  • EVLV $30.41
  • P/E Ratio
  • PLRX N/A
  • EVLV N/A
  • Revenue Growth
  • PLRX N/A
  • EVLV 17.67
  • 52 Week Low
  • PLRX $10.22
  • EVLV $2.01
  • 52 Week High
  • PLRX $18.92
  • EVLV $5.73
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 31.55
  • EVLV 35.53
  • Support Level
  • PLRX $12.40
  • EVLV $2.98
  • Resistance Level
  • PLRX $13.71
  • EVLV $4.21
  • Average True Range (ATR)
  • PLRX 0.77
  • EVLV 0.23
  • MACD
  • PLRX -0.22
  • EVLV -0.12
  • Stochastic Oscillator
  • PLRX 6.80
  • EVLV 13.01

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: